• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nilotinib: from animal-based studies to clinical investigation in Alzheimer's disease patients.

作者信息

Nobili Annalisa, D'Amelio Marcello, Viscomi Maria Teresa

机构信息

Department of Medicine and Surgery, University Campus Bio-Medico; Department of Experimental Neuroscience, IRCCS Santa Lucia Foundation, Rome, Italy.

Department of Life Science and Public Health Section of Histology and Embryology, Università Cattolica del Sacro Cuore; Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.

出版信息

Neural Regen Res. 2023 Apr;18(4):803-804. doi: 10.4103/1673-5374.350700.

DOI:10.4103/1673-5374.350700
PMID:36204843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9700081/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5218/9700081/95d309ea9fa8/NRR-18-803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5218/9700081/95d309ea9fa8/NRR-18-803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5218/9700081/95d309ea9fa8/NRR-18-803-g001.jpg

相似文献

1
Nilotinib: from animal-based studies to clinical investigation in Alzheimer's disease patients.尼洛替尼：从基于动物的研究到阿尔茨海默病患者的临床研究
Neural Regen Res. 2023 Apr;18(4):803-804. doi: 10.4103/1673-5374.350700.
2
Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer's Disease.尼罗替尼改善阿尔茨海默病3xTg小鼠模型中脑星形胶质细胞的生物能量特征。
Aging Dis. 2021 Apr 1;12(2):441-465. doi: 10.14336/AD.2020.0910. eCollection 2021 Apr.
3
Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review.重新利用蛋白质稳态调节药物预防或治疗年龄相关性痴呆：一项系统评价
Front Physiol. 2018 Oct 30;9:1520. doi: 10.3389/fphys.2018.01520. eCollection 2018.
4
Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models.尼罗替尼和博舒替尼可调节阿尔茨海默病模型中血液免疫标志物的斑块前改变和神经炎症。
Neuroscience. 2015 Sep 24;304:316-27. doi: 10.1016/j.neuroscience.2015.07.070. Epub 2015 Jul 30.
5
Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance.尼洛替尼诱导的自噬变化增加内源性 parkin 水平和泛素化，导致淀粉样蛋白清除。
J Mol Med (Berl). 2014 Apr;92(4):373-86. doi: 10.1007/s00109-013-1112-3. Epub 2013 Dec 13.
6
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease.有些动物模型比其他模型更平等吗？以阿尔茨海默病疗效动物模型的转化价值为例。
Eur J Pharmacol. 2019 Sep 15;859:172524. doi: 10.1016/j.ejphar.2019.172524. Epub 2019 Jul 7.
7
The role of trimethylamine-N-Oxide in the development of Alzheimer's disease.氧化三甲胺在阿尔茨海默病发展中的作用。
J Cell Physiol. 2022 Mar;237(3):1661-1685. doi: 10.1002/jcp.30646. Epub 2021 Nov 23.
8
[Involvement of the olfactory system in learning and memory: a close correlation between the olfactory deficit and the course of Alzheimer's disease?].[嗅觉系统在学习与记忆中的作用：嗅觉缺陷与阿尔茨海默病病程之间的密切关联？]
Yakubutsu Seishin Kodo. 1991 Aug;11(4):223-35.
9
Reply to "Cardiovascular Safety of Nilotinib in Alzheimer's Disease".对“尼洛替尼在阿尔茨海默病中的心血管安全性”的回复
Ann Neurol. 2021 Jan;89(1):196-197. doi: 10.1002/ana.25946. Epub 2020 Nov 6.
10
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib.尼洛替尼用于治疗对伊马替尼和舒尼替尼均耐药的晚期胃肠道间质瘤。
Eur J Cancer. 2009 Sep;45(13):2293-7. doi: 10.1016/j.ejca.2009.04.030. Epub 2009 May 19.

引用本文的文献

1
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib.BCR-ABL抑制剂多药理学格局的计算洞察：重点关注伊马替尼和尼洛替尼。
Pharmaceuticals (Basel). 2025 Jun 20;18(7):936. doi: 10.3390/ph18070936.
2
Beyond expectations: investigating nilotinib's potential in attenuating neurodegeneration in alzheimer's disease.超乎预期：探究尼罗替尼在减轻阿尔茨海默病神经退行性变方面的潜力。
Alzheimers Res Ther. 2025 Mar 15;17(1):60. doi: 10.1186/s13195-025-01706-w.
3
Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer's disease.

本文引用的文献

1
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases.在阿尔茨海默病各阶段对多巴胺能易损性进行的活体人类分子神经影像学研究。
Alzheimers Res Ther. 2021 Nov 12;13(1):187. doi: 10.1186/s13195-021-00925-1.
2
Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer's Disease.尼罗替尼改善阿尔茨海默病3xTg小鼠模型中脑星形胶质细胞的生物能量特征。
Aging Dis. 2021 Apr 1;12(2):441-465. doi: 10.14336/AD.2020.0910. eCollection 2021 Apr.
3
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease.
阿尔茨海默病中的自噬-溶酶体途径损伤与组织蛋白酶失调
Front Mol Biosci. 2024 Oct 31;11:1490275. doi: 10.3389/fmolb.2024.1490275. eCollection 2024.
4
Nilotinib as a Prospective Treatment for Alzheimer's Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis.尼罗替尼作为阿尔茨海默病的一种潜在治疗方法：对参与神经退行性变和神经元稳态的蛋白质的影响。
Life (Basel). 2024 Sep 28;14(10):1241. doi: 10.3390/life14101241.
5
Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.截至2024年6月1日处于III期试验阶段的在研精神科药物概述：一项系统评价
Innov Clin Neurosci. 2024 Sep 1;21(7-9):27-47. eCollection 2024 Jul-Sep.
6
Loss of glycine receptors in the nucleus accumbens and ethanol reward in an Alzheimer´s Disease mouse model.伏隔核中甘氨酸受体缺失与阿尔茨海默病小鼠模型中的乙醇奖赏。
Prog Neurobiol. 2024 Jun;237:102616. doi: 10.1016/j.pneurobio.2024.102616. Epub 2024 May 7.
7
Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation.利用生成式人工智能对阿尔茨海默病药物再利用候选药物进行优先级排序，并进行真实世界临床验证。
NPJ Digit Med. 2024 Feb 26;7(1):46. doi: 10.1038/s41746-024-01038-3.
8
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease.蛋白质稳态与神经退行性变：深入探讨阿尔茨海默病中的自噬
Front Aging Neurosci. 2023 Nov 2;15:1281338. doi: 10.3389/fnagi.2023.1281338. eCollection 2023.
9
Upregulation of Ca-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice.钙结合蛋白的上调有助于 Tg2576 小鼠阿尔茨海默病早期阶段中 VTA 多巴胺神经元的存活。
Mol Neurodegener. 2022 Nov 25;17(1):76. doi: 10.1186/s13024-022-00580-6.
尼洛替尼通过防止阿尔茨海默病小鼠模型中多巴胺能神经元退化来恢复记忆功能。
Prog Neurobiol. 2021 Jul;202:102031. doi: 10.1016/j.pneurobio.2021.102031. Epub 2021 Mar 5.
4
Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study.轻度认知障碍的脑代谢和小胶质细胞激活：[18F]FDG 和 [11C]-(R)-PK11195 PET 的联合研究。
J Alzheimers Dis. 2021;80(1):433-445. doi: 10.3233/JAD-201351.
5
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease.尼洛替尼对阿尔茨海默病的安全性、耐受性和生物标志物的影响。
Ann Neurol. 2020 Jul;88(1):183-194. doi: 10.1002/ana.25775. Epub 2020 May 28.
6
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease.神经退行性疾病中多巴胺能神经元丢失的统一假说：聚焦于阿尔茨海默病
Front Mol Neurosci. 2019 May 17;12:123. doi: 10.3389/fnmol.2019.00123. eCollection 2019.
7
In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease.阿尔茨海默病中脑干核团功能连接破坏的体内图谱。
Neurobiol Aging. 2018 Dec;72:72-82. doi: 10.1016/j.neurobiolaging.2018.08.012. Epub 2018 Aug 23.
8
Volume and Connectivity of the Ventral Tegmental Area are Linked to Neurocognitive Signatures of Alzheimer's Disease in Humans.腹侧被盖区的体积和连通性与人类阿尔茨海默病的神经认知特征有关。
J Alzheimers Dis. 2018;63(1):167-180. doi: 10.3233/JAD-171018.
9
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.多巴胺神经元的丧失导致阿尔茨海默病模型中的记忆和奖励功能障碍。
Nat Commun. 2017 Apr 3;8:14727. doi: 10.1038/ncomms14727.
10
Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models.尼罗替尼和博舒替尼可调节阿尔茨海默病模型中血液免疫标志物的斑块前改变和神经炎症。
Neuroscience. 2015 Sep 24;304:316-27. doi: 10.1016/j.neuroscience.2015.07.070. Epub 2015 Jul 30.